Search results - ORA - Oxford University Research Archive

1 - 10 of 10

1

Journal article

Genomics reveals the worldwide distribution of multidrug-resistant serotype 6E pneumococci.

van Tonder, A, Bray, J, Roalfe, L, et al.
2015-07-01

2

Journal article

Anamnestic immune response and safety of an inactivated quadrivalent influenza vaccine in primed versus vaccine-naïve children

Claeys, C, Chandrasekaran, V, García-Sicilia, J, et al.
2018-10-15

3

Journal article

Effect of vaccination on pneumococci isolated from the nasopharynx of healthy children and the middle ear of children with otitis media in Iceland

Quirk, S, Haraldsson, G, Erlendsdóttir, H, et al.
2018-09-26

4

Journal article

Potential coverage of the 4CMenB vaccine against invasive serogroup B Neisseria meningitidis isolated from 2009 to 2013 in the Republic of Ireland

Mulhall, R, Bennett, D, Cunney, R, et al.
2018-08-22

5

Journal article

Enhanced safety surveillance of seasonal quadrivalent influenza vaccines in English Primary Care: interim analysis

De Lusignan, S, Dos Santos, G, Byford, R, et al.
2018-07-11

6

Journal article

B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents

Marshall, HS, McMillan, M, Koehler, A, et al.
2018-07-10

7

Journal article

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.

Pan-Ngum, W, Kinyanjui, T, Kiti, M, et al.
2016-11-30

8

Journal article

Analysis of B cell repertoire dynamics following hepatitis B vaccination in humans, and enrichment of vaccine-specific antibody sequences

Galson, J, Trück, J, Fowler, A, et al.
2015-12-01

9

Journal article

Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal

Venkatraman, N, Ndiaye, B, Bowyer, G, et al.
2018-11-08

10

Journal article

A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK

Marlow, R, Kuriyakose, S, Mesaros, N, et al.
2018-03-22

TO TOP